Pierre-Yves Le Roux Selected Research

Gallium-68

4/2022	Quantitative assessment of ventilation-perfusion relationships with gallium-68 positron emission tomography/computed tomography imaging in lung cancer patients.
1/2021	Radiation Therapy Planning of Thoracic Tumors: A Review of Challenges Associated With Lung Toxicities and Potential Perspectives of Gallium-68 Lung PET/CT Imaging.
7/2020	Correlation of positron emission tomography ventilation-perfusion matching with CT densitometry in severe emphysema.
1/2020	Gallium-68 Ventilation/Perfusion PET-CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: An Interobserver Agreement Study.
8/2016	Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre-Yves Le Roux Research Topics

Disease

10	Pulmonary Embolism 01/2022 - 05/2012
7	Neoplasms (Cancer) 01/2022 - 11/2016
5	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2016
5	Squamous Cell Carcinoma of Head and Neck 04/2014 - 01/2009
2	Venous Thromboembolism 01/2020 - 11/2018
2	Neoplasm Metastasis (Metastasis) 11/2016 - 01/2009
2	Melanoma (Melanoma, Malignant) 11/2016 - 09/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Lung Injury 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Emphysema 07/2020
1	Pneumonia (Pneumonitis) 11/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2019
1	Thrombosis (Thrombus) 07/2019
1	Hemorrhage 07/2019
1	Neurilemmoma (Schwannoma) 01/2018
1	Adenocarcinoma 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2015
1	Paresis (Hemiparesis) 06/2015
1	Vitelliform Macular Dystrophy 12/2012
1	Hodgkin Disease (Hodgkin's Disease) 06/2011

Drug/Important Bio-Agent (IBA)

6	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2022 - 09/2015
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2009
5	Gallium-68IBA 04/2022 - 08/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2018
2	fibrin fragment D (D-dimer)IBA 01/2020 - 05/2012
2	AnticoagulantsIBA 07/2019 - 11/2018
2	Deoxyglucose (2 Deoxy D glucose)IBA 06/2011 - 09/2010
1	GalliumIBA 04/2022
1	Carbon MonoxideIBA 04/2022
1	IodineIBA 09/2020
1	KryptonIBA 11/2019
1	diethylenetriamineIBA 11/2019
1	TechnegasIBA 11/2019
1	AcidsIBA 11/2019
1	Pentetic Acid (DTPA)FDA LinkGeneric 11/2019
1	Antiphospholipid AntibodiesIBA 01/2018
1	vermiculiteIBA 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 12/2012
1	Fluorouracil (Carac)FDA LinkGeneric 12/2012
1	Docetaxel (Taxotere)FDA Link 12/2012
1	Fluorine-18IBA 04/2012

Therapy/Procedure

4	Radiotherapy 01/2021 - 11/2015
4	Therapeutics 01/2020 - 11/2016
2	Aftercare (After-Treatment) 01/2020 - 01/2009
2	Contraindications 11/2019 - 09/2015
1	Pneumonectomy (Lung Volume Reduction) 01/2019
1	Operative Surgical Procedures 01/2018
1	Denervation 06/2015
1	Chemoradiotherapy 12/2012
1	Induction Chemotherapy 12/2012